Combining expression of GPC3 in tumors and CD16 on NK cells from peripheral blood to identify patients responding to codrituzumab.
about
Combining expression of GPC3 in tumors and CD16 on NK cells from peripheral blood to identify patients responding to codrituzumab.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Combining expression of GPC3 i ...... ts responding to codrituzumab.
@en
Combining expression of GPC3 i ...... ts responding to codrituzumab.
@nl
type
label
Combining expression of GPC3 i ...... ts responding to codrituzumab.
@en
Combining expression of GPC3 i ...... ts responding to codrituzumab.
@nl
prefLabel
Combining expression of GPC3 i ...... ts responding to codrituzumab.
@en
Combining expression of GPC3 i ...... ts responding to codrituzumab.
@nl
P2093
P2860
P356
P1433
P1476
Combining expression of GPC3 i ...... nts responding to codrituzumab
@en
P2093
Anton Belousov
Axel Muehlig
Bernhard Reis
Christine Rossin
Laura Di Laurenzio
Laurent Essioux
Lori Jukofsky
P2860
P304
10436-10444
P356
10.18632/ONCOTARGET.23830
P407
P50
P577
2018-01-02T00:00:00Z